AzTrials
AzTrials

Autism Spectrum DisorderNCT05114538

Improving the Part C Early Intervention Service Delivery System for Children With ASD

A study testing Reciprocal Imitation Training in people with Autism Spectrum Disorder, run by Rush University Medical Center at 4 sites in United States.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

Despite strong consensus that early, specialized intervention for children with autism spectrum disorder (ASD) can have a dramatic impact on outcomes, the public health system's capacity to provide such services is severely challenged by the rapid rise in ASD prevalence. Read more about this study

Who is it for?
Ages 16 to 33 months
Conditions the study is for
Autism Spectrum Disorder
What is being tested?
Reciprocal Imitation Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
440 participants
Where
4 sitesUnited States
Study dates
27 Sep 2021to 31 May 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 33 months
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Child has a diagnosis of ASD or displays early social communication challenges
  • Child receives ≥ 1 weekly session with the participating provider (not co-treated with another provider)
  • Caregiver is present during EI sessions
  • Caregiver is the biological parent or custodial guardian
  • Caregiver is at least 18 years of age
  • Caregiver speaks either English or Spanish

Who cannot join

  • the child has visual, hearing, or motor conditions that would compromise his/her ability to participate in RIT or assessments

Trial locations and contacts

4 sites in 1 country.

United States4 sites
  • University of Massachusetts Boston

    Boston, Massachusetts, 02125

  • Rush University Medical Center

    Chicago, Illinois, 60612

  • Michigan State University

    East Lansing, Michigan, 48824

  • Carol A Schubert

    Seattle, Washington, 98195

Other trials in United States

About this study

Official title: Improving the Part C Early Intervention Service Delivery System for Children With ASD: A Randomized Clinical Trial

Despite strong consensus that early, specialized intervention for children with autism spectrum disorder (ASD) can have a dramatic impact on outcomes, the public health system's capacity to provide such services is severely challenged by the rapid rise in ASD prevalence. The goal of this research project is to increase timely and equitable access to ASD-specialized early intervention during the critical first three years of life by capitalizing on the existing infrastructure of the Part C Early Intervention (EI) system, which is publicly funded and available in all states in the United States. This project will train EI providers to use an evidence-based, parent-mediated intervention that can improve child and family outcomes as well as mitigate the long-term substantial economic costs associated with ASD.

Read the detailed description

The long-term goal of this study is to improve services and outcomes for children with early social communication challenges and/or ASD by increasing the capacity to provide appropriately specialized treatment within an existing infrastructure: the Part C Early Intervention (EI) service delivery system. Part C is publicly funded, available throughout the United States, and serves children under age 3 who have developmental delays or disabilities. Currently, the effectiveness of EI services is limited by high practice variation and infrequent use of evidence-based interventions. We are conducting a randomized controlled trial (RCT) to examine the effectiveness of training EI providers to deliver Caregiver-Implemented Reciprocal Imitation Teaching (CI-RIT) to children showing early social communication challenges. RIT is a naturalistic developmental behavioral intervention (NDBI) that is ideally suited for EI settings because it is low intensity, play-based, easy to learn and implement, and can be taught to families for their independent use (in the form of CI-RIT), thus increasing intervention dosage.

This RCT will employ a hybrid type 1 effectiveness/ implementation design and will use a unique mixed methods approach to gather evidence that will be essential for implementing RIT at scale, pending positive trial results. The sample includes a target of 20 EI agencies (across 4 U.S. States), 160 EI providers and 440 families of children with early social communication challenges, which not only provides a robust sample size, but also affords the opportunity to assess the generalizability of this approach across regions that vary in their implementation of Part C services. EI providers will be randomly assigned to the RIT training group (n=80) or treatment as usual (TAU; n=80). Providers in both groups will identify 2-5 children in their caseload who are 16-33 months old with early social communication delays (target n=220 children per group). Intensive, state-of-the art, multimethod assessment technology will be used to measure the impact of the intervention. Child and family assessments will be conducted at baseline, 4 months after enrollment, and 9 months after enrollment. Importantly, this study will examine putative mechanisms through which RIT improves clinically-relevant outcomes. In sum, this study will generate the evidence necessary to implement RIT at scale, thereby increasing the capacity of the existing EI system to deliver effective, evidence-based intervention to the rapidly growing population of children who show early social communication challenges.

The objectives of the RISE study are as follows:

  1. To test the effectiveness of CI-RIT as delivered by community-based EI providers for improving child- and caregiver/family-level outcomes. We hypothesize that compared to TAU, children working with CI-RIT providers will demonstrate greater improvements in motor imitation and joint attention at T2 (4-months post-baseline), and language and social communication at T3 (9-months post-baseline). We also hypothesize that compared to TAU, caregivers working with CI-RIT providers will show greater improvements in contingent responsivity, RIT strategy use, parenting efficacy, and family quality of life.
  2. To analyze the mechanisms by which CI-RIT improves outcomes. We hypothesize that changes in children's social communication and language outcomes will be serially mediated by gains in: (a) caregiver contingent responsivity and caregiver RIT strategy use, and (b) children's motor imitation and joint attention. We hypothesize that changes in caregiver/family outcomes will be mediated by gains in caregiver contingent responsivity, caregiver RIT strategy use, child motor imitation, and child joint attention.
  3. To prepare for implementation at scale by identifying potential sources of practice variation to inform refinement of RIT training and development of quality assurance protocols. Triangulating evidence from video observations of EI sessions, EI provider self-reports, and qualitative interviews, we will use the Model for Adaptation Design (MADI) framework (32) to characterize the modifications to RIT that providers make (MADI domain 1), to identify potential mediating or moderating factors of these modifications (e.g., relationship to fidelity, rationale) (MADI domain 2), and to explore whether all or certain modifications influence implementation outcomes (e.g., ongoing fidelity, treatment acceptability) (MADI domain 3). This robust implementation evaluation will provide relevant information for improving the delivery of all NDBIs in the Part C system.
Being tested
Reciprocal Imitation Training
Medical subject headings
Autism Spectrum Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Reciprocal Imitation TrainingBehavioural

    RIT is a relatively straightforward, brief NDBI. It employs four simple strategies to target motor imitation and IJA during play: (1) contingent imitation of the child's verbal and nonverbal behavior, (2) linguistic mapping, (3) direct elicitation of object and gesture imitation following the child's interest, and (4) contingent reinforcement. It has been used at low intensities (e.g., 1-3 hours per week) over short periods of time (e.g., 10-12 weeks) to produce robust changes in pivotal skills. It is easy to learn and can be implemented with fidelity by undergraduate-level therapists with limited backgrounds in ASD, as well as by parents and siblings.

Study groups in NCT05114538
Study groupRoleWhat they receive
RIT Training GroupExperimentalProviders in the RIT group (n=80) will receive intensive training (online tutorial, 2-day workshop, and virtual coaching and feedback in the field) in RIT and parent coaching and will be required to achieve fidelity prior to enrolling families from their caseload. They will then be asked to use the intervention with enrolled families for a minimum of 3 months. One intervention session per month for each enrolled family will be videotaped and scored for fidelity. Providers will receive monthly consultation from RIT trainers while these families are in the active treatment phase.
Receives: Behavioral: Reciprocal Imitation Training
Treatment as UsualNo interventionProviders in the TAU group (n=80) will have three sessions videotaped and scored for each enrolled family to assess treatment differentiation. To incentivize agency participation, RIT training will be provided to the TAU group and other providers when data collection is complete.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Unstructured Imitation

    An adapted version of the UIA coding protocol (Ingersoll, 2012) will be used to measure spontaneous motor imitation within a virtual administration of an adapted version of the Communication Play Protocol (CPP; Adamson et al., 2004, Tagavi et al., 2025).

    Measured: Change from baseline to 4 months

Secondary outcomes (12)
  1. Parenting Efficacy Scale (PES)

    The PES Total Score will be used to measure parenting efficacy.

    Measured: Change from baseline to 9 months

  2. MacArthur Bates Communicative Development Inventory (MCDI)

    The total number of words said on the MCDI will be used to measure expressive vocabulary.

    Measured: Change from baseline to 9 months

  3. CI-RIT Caregiver Fidelity Form

    The CI-RIT Caregiver Fidelity Form will be used to measure caregiver fidelity of the RIT strategies from caregiver- child interaction videos.

    Measured: Change from baseline to 4 months

  4. The Parenting Interactions with Children: Checklist of Observations Linked to Outcomes (PICCOLO)

    The PICOOLO coding protocol will be used to measure caregiver responsivity from caregiver- child interaction videos.

    Measured: Change from baseline to 4 months

  5. Weighted Frequency of Intentional Communication

    The Weighted Frequency of Intentional Communication coding protocol will be used to measure expressive communication during a virtual administration of an adapted version of the Communication Play Protocol (CPP; Adamson et al., 2004).

    Measured: Change from baseline to 9 months

  6. Language Environment Analysis (LENA) Vocal Complexity

    Child vocal complexity will be based on recorded language using LENA Software.

    Measured: Change from baseline to 9 months

  7. Vineland-3

    The Growth Scale Values (GSVs) from the communication and social subdomains on the Vineland-3 will be used to measure child social communication.

    Measured: Change from baseline to 9 months

  8. Language Environment Analysis (LENA) Vocal Contingency

    Child reciprocal vocal contingency will be based on recorded language using the LENA software.

    Measured: Change from baseline to 9 months

  9. Parent Interview for Autism-Clinical Version (PIA-CV)

    Social Communication domains from the PIA-CV will be used to measure child social communication.

    Measured: Change from baseline to 9 months

  10. Initiation of Joint Attention

    An adapted version of the ESCS coding protocol (Roos et al., 2008) will be used to measure initiation of joint attention within a virtual administration of an adapted version of the Communication Play Protocol (CPP; Adamson et al., 2004, Tagavi et al., 2025).

    Measured: Change from baseline to 4 months

  11. Family Life Impairment Scale (FLIS)

    The FLIS Total Impairment Score will be used to measure family well-being.

    Measured: Change from baseline to 9 months

  12. Adapted Motor Imitation Scale (MIS)

    Elicited motor imitation will be assessed using a virtually-administered version of the Motor Imitation Scale (MIS) within a virtual administration of an adapted version of the Communication Play Protocol (CPP; Adamson et al., 2004; Tagavi et al., 2025).

    Measured: Change from baseline to 4 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Nov 2021
  2. Study start27 Sep 2021
  3. Primary completion31 May 2026
  4. Study completion31 May 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Enrollment: 440 parent-child dyads; 160 providers (anticipated)
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
440 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05114538
Sponsor's protocol ID
STUDY00009835
Other IDs
1R01MH122727-01
Status last verified
Jul 2026
First submitted
6 Oct 2021
Last updated
7 Jul 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Nadwodny N, Yoder PJ, Ingersoll BR, Wainer AL, Stone WL, Eisenhower A, Carter AS; RISE Research Network. The Language ENvironment Analysis (LENA) System in Toddlers With Early Indicators of Autism: Test-Retest Reliability and Convergent Validity With Clinical Language Assessments. Autism Res. 2025 Aug;18(8):1568-1579. doi: 10.1002/aur.70062. Epub 2025 Jun 2.

    PubMed 40452405
  • Wainer AL, Edmunds SR, Carter AS, Stone WL, Sheldrick RC, Broder-Fingert S, Stern YS, Harrington E, V Ibanez L, Ingersoll B. A hybrid type I randomized effectiveness-implementation trial of a Naturalistic Developmental Behavioral Intervention in the Part C early intervention system: study protocol. BMC Pediatr. 2025 Apr 1;25(1):263. doi: 10.1186/s12887-025-05587-8.

    PubMed 40170032
  • Ingersoll B, Howard M, Oosting D, Carter AS, Stone WL, Berger N, Wainer AL, Britsch ER; RISE Research Network. Adapting measures of motor imitation for use by caregivers in virtual contexts: Reliability, validity, and sensitivity to change. Autism Res. 2025 Jan;18(1):122-132. doi: 10.1002/aur.3267. Epub 2024 Nov 21.

    PubMed 39569704
  • Ingersoll B, Espinel A, Nauman J, Broder-Fingert S, Carter AS, Sheldrick RC, Stone WL, Wainer AL. Using virtual multiteam systems to conduct a multisite randomized clinical trial in the part C early intervention system: Benefits, challenges, and lessons learned. Contemp Clin Trials. 2024 Aug;143:107585. doi: 10.1016/j.cct.2024.107585. Epub 2024 May 29.

    PubMed 38821261

Questions about this trial

What is this clinical trial studying?

A study testing Reciprocal Imitation Training in people with Autism Spectrum Disorder, run by Rush University Medical Center at 4 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 7 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Unstructured Imitation (time frame: Change from baseline to 4 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05114538, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Jul 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in